Chris E. Holmes

2.6k total citations · 1 hit paper
58 papers, 1.8k citations indexed

About

Chris E. Holmes is a scholar working on Internal Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Chris E. Holmes has authored 58 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Internal Medicine, 18 papers in Oncology and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Chris E. Holmes's work include Venous Thromboembolism Diagnosis and Management (27 papers), Platelet Disorders and Treatments (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Chris E. Holmes is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (27 papers), Platelet Disorders and Treatments (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Chris E. Holmes collaborates with scholars based in United States, Netherlands and France. Chris E. Holmes's co-authors include Nadia M. Bambace, Deva Sharma, Sidney M. Hecht, Kathleen E. Brummel‐Ziedins, Beth A. Bouchard, Kim Dittus, Mary Cushman, Barbara J. Carter, Steven Ades and Deborah L. Ornstein and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Chris E. Holmes

56 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The platelet contribution to cancer progression

2010 533 citations Nadia M. Bambace, Chris E. Holmes Journal of Thrombosis and Haemostasis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris E. Holmes United States	19	782	420	365	351	298	58	1.8k
Vivien Chen Australia	23	302 0.4×	382 0.9×	253 0.7×	783 2.2×	144 0.5×	93	2.0k
Xiaolei Zhu China	14	830 1.1×	604 1.4×	235 0.6×	156 0.4×	201 0.7×	35	2.1k
Laura Russo Italy	22	261 0.3×	399 0.9×	652 1.8×	575 1.6×	88 0.3×	56	1.7k
Jamey Skillings Canada	18	1.3k 1.6×	281 0.7×	126 0.3×	180 0.5×	260 0.9×	40	2.1k
Ingvar Syk Sweden	29	1.3k 1.6×	356 0.8×	177 0.5×	138 0.4×	219 0.7×	86	2.6k
Som D. Mukherjee Canada	25	968 1.2×	560 1.3×	72 0.2×	110 0.3×	414 1.4×	85	2.0k
Hikmat Abdel‐Razeq Jordan	17	481 0.6×	138 0.3×	225 0.6×	132 0.4×	235 0.8×	155	1.2k
Fabio A.B. Schutz United States	21	1.4k 1.8×	638 1.5×	132 0.4×	150 0.4×	281 0.9×	46	2.9k
Sung‐Hyun Kim South Korea	17	371 0.5×	213 0.5×	117 0.3×	352 1.0×	95 0.3×	105	1.0k
Sergio Siragusa Italy	26	242 0.3×	360 0.9×	748 2.0×	960 2.7×	93 0.3×	150	2.1k

Countries citing papers authored by Chris E. Holmes

Since Specialization

Citations

This map shows the geographic impact of Chris E. Holmes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris E. Holmes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris E. Holmes more than expected).

Fields of papers citing papers by Chris E. Holmes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris E. Holmes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris E. Holmes. The network helps show where Chris E. Holmes may publish in the future.

Co-authorship network of co-authors of Chris E. Holmes

This figure shows the co-authorship network connecting the top 25 collaborators of Chris E. Holmes. A scholar is included among the top collaborators of Chris E. Holmes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris E. Holmes. Chris E. Holmes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sparks, Andrew, Nicholas S. Roetker, Hanny Al‐Samkari, et al.. (2025). Anticoagulation and other risk factors for clinically relevant bleeding after medical hospitalization: the Medical Inpatient Thrombosis and Hemostasis Study. Journal of Thrombosis and Haemostasis. 23(7). 2122–2132. 1 indexed citations

Holmes, Chris E., et al.. (2025). Acute myocardial infarction in patients with cancer: outcomes and P2Y12 inhibition. Journal of Thrombosis and Thrombolysis. 58(4). 538–546.

Ganguly, Eric K., et al.. (2024). Venous thromboembolism in patients with pancreatic adenocarcinoma: Disease burden and initiation of ambulatory thromboprophylaxis. Pancreatology. 24(6). 894–898. 1 indexed citations

Koh, Insu, Hanny Al‐Samkari, Nicholas L. Smith, et al.. (2023). The relative risk of bleeding after medical hospitalization: the medical inpatient thrombosis and hemorrhage study. Journal of Thrombosis and Haemostasis. 21(3). 513–521. 3 indexed citations

Ades, Steven & Chris E. Holmes. (2023). Implementing guidelines to prevent cancer associated thrombosis: how can we do better?. Research and Practice in Thrombosis and Haemostasis. 7(1). 100038–100038. 8 indexed citations

Koh, Insu, Pamela L. Lutsey, Nicholas S. Roetker, et al.. (2022). Venous thrombosis risk during and after medical and surgical hospitalizations: The medical inpatient thrombosis and hemostasis (MITH) study. Journal of Thrombosis and Haemostasis. 20(7). 1645–1652. 16 indexed citations

Ades, Steven, et al.. (2018). Effect of rosuvastatin on risk markers for venous thromboembolism in cancer. Journal of Thrombosis and Haemostasis. 16(6). 1099–1106. 9 indexed citations

Ades, Steven, et al.. (2017). Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic (VTE-PACC): a Systems-Based, Personalized, Multidisciplinary Program to Increase Venous Thromboembolism (VTE) Risk Assessment, Education and Anticoagulant Prophylaxis in Cancer Outpatients Initiating Therapy. Blood. 130. 217–217. 2 indexed citations

Kelm, Robert J., et al.. (2017). Characterization of purine‐rich element binding protein B as a novel biomarker in acute myelogenous leukemia prognostication. Journal of Cellular Biochemistry. 119(2). 2073–2083. 11 indexed citations

10.

Waheed, Waqar, et al.. (2016). Spinal Cord Infarction in a Patient with Hereditary Spherocytosis: A Case Report and Discussion. SHILAP Revista de lepidopterología. 2016. 1–7. 3 indexed citations

11.

Morris, Christopher S., et al.. (2016). A multidisciplinary quality improvement program increases the inferior vena cava filter retrieval rate. Vascular Medicine. 22(1). 51–56. 19 indexed citations

12.

Holmes, Chris E., et al.. (2014). Efficacy of a short course of complex lymphedema therapy or graduated compression stocking therapy in the treatment of post-thrombotic syndrome. Vascular Medicine. 19(1). 42–48. 18 indexed citations

13.

Bambace, Nadia M., et al.. (2010). The effect of P2Y-mediated platelet activation on the release of VEGF and endostatin from platelets. Platelets. 21(2). 85–93. 81 indexed citations

14.

Holmes, Chris E., Maria E. Ramos‐Niño, & Benjamin Littenberg. (2010). An association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont Diabetes Information System Study. BMC Cancer. 10(1). 3 indexed citations

15.

Holmes, Chris E., et al.. (2009). Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis. Clinical & Experimental Metastasis. 26(7). 653–661. 44 indexed citations

16.

Bom, Johanna G. van der, Susan R. Heckbert, Thomas Lumley, et al.. (2008). Platelet count and the risk for thrombosis and death in the elderly. Journal of Thrombosis and Haemostasis. 7(3). 399–405. 73 indexed citations

17.

Schneider, David J., et al.. (2007). Contributions of young platelets and of previously activated platelets to platelet reactivity in patients with coronary artery disease. Thrombosis Research. 121(4). 455–462. 5 indexed citations

18.

Holmes, Chris E., et al.. (2007). Influence of Preparative Procedures on Assay of Platelet Function and Apparent Effects of Antiplatelet Agents. The American Journal of Cardiology. 100(4). 722–727. 9 indexed citations

19.

Holmes, Chris E.. (1996). Fe.bleomycin as a probe of RNA conformation. Nucleic Acids Research. 24(17). 3399–3406. 17 indexed citations

20.

Holmes, Chris E., Barbara J. Carter, & Sidney M. Hecht. (1993). Characterization of iron(II).cntdot.bleomycin-mediated RNA strand scission. Biochemistry. 32(16). 4293–4307. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact